NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice
Open Access
- 1 February 2022
- Vol. 25 (2) , 103847
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation
- NIH
This publication has 38 references indexed in Scilit:
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with HepatocytesCancer Cell, 2014
- Tumor-Associated Macrophages: From Mechanisms to TherapyImmunity, 2014
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial CancerScience, 2014
- Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinomaJournal of Hepatology, 2013
- Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinomaHepatology, 2013
- Expression of tumour-specific antigens underlies cancer immunoeditingNature, 2012
- Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie dietInternational Journal of Experimental Pathology, 2011
- Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor ProgressionCancer Cell, 2011
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic CellsJournal of Experimental Medicine, 2004